Life science communications. To progress, life science companies require investment, developmental partners, and clear engagement with the research and medical communities. 80th Atom is a consultancy that develops bespoke communications programmes supporting its clients to access capital, establish and progress relationships with commercial partners, gain access to and influence KOLs, all through building strong credible brands. Adam Michael, founder of 80th Atom, has over 20 years experience in the sector covering drug development, medtech, and diagnostics, from academic spin-outs to multinational corporations. He has operated throughout the industry, within the media, financial services, business development, KOL engagement and patient recruitment. This broad understanding and experience of the sector enables 80th Atom to anticipate its clients' near and long-term requirements, and provide strategic access to the full-scope of communications channels open to them.